• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

The Human Nose Might Be Home To The Next New Antibiotic

December 20, 2023 by Deborah Bloomfield

With a rise in antibiotic-resistant infections, the search for a new, effective antibiotic is as important as ever. On the hunt for such a substance, researchers believe they may well have found one, and it occurs naturally in a somewhat unexpected place: the human nose.

Scientists at the University of Tübingen discovered epifadin, a member of a previously unknown class of antimicrobial compounds, being produced by Staphylococcus epidermidis. This bacterial species can be found inside our noses, as well as on the skin.

Advertisement

The human body is home to all sorts of bacteria – collectively known as the microbiome – that are in a constant battle to outcompete each other for survival. Secreting substances like epifadin is thought to be one of the ways in which S. epidermidis knocks out its local bacterial competitors. 

One such opponent is Staphylococcus aureus, a bacteria that is naturally found in human airways but can turn into an opportunistic pathogen. It’s well known for its methicillin-resistant form, MRSA, a particularly dangerous infection. During experiments, however, the research team discovered that epifadin was reliably effective at killing S. aureus off, doing so by damaging the cell membrane to the point of lethality. This hints at the power that epifadin, or derivatives of it, could have as a brand-new antibiotic.

A flask containing epifadin in its isolated pure form.

Epifadin in its isolated pure form.

Image credit: ©Jonas Ritz, CMFI/University of Tübingen (CC BY)

The researchers also found that the chemical structure of epifadin is unstable. Whilst that can make it difficult to isolate and analyze – successful isolation took the team several years – it could prove to be useful in the form of a treatment. The human microbiome plays host to many helpful bacteria, which can sometimes end up as collateral damage when currently available broad-spectrum antibiotics are used – that’s why taking antibiotics can sometimes give you tummy trouble. Epifadin, however, is only active for a few hours, meaning it has a much more localized effect.

Further studies are being planned to investigate how the different elements of epifadin’s structure contribute to its effects, as well as the development of artificial, more stable substances that are similar to epifadin.

Advertisement

Regardless of whether epifadin forms the basis of the next big antibiotic wonder drug, the researchers believe its discovery highlights the importance of continuing the search for the antibiotics of the future.

As microbiologist and study author Andreas Peschel concluded in a statement: “The development of new antibiotics has stagnated for decades. But we need them more than ever, because in recent years we’ve registered a rapid rise in multiresistant bugs worldwide. It is hard to get control of these infections and our reserve antibiotics no longer have such a strong effect. We urgently need new active substances and treatment methods.”



The study is published in Nature Microbiology.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Paris ramps up security as jihadist attacks trial starts
  2. Cricket-‘Western bloc’ has let Pakistan down, board chief says
  3. Ancient Bison Found In Permafrost Is So Well Preserved Scientists Want To Clone It
  4. Where Inside Us Do We Feel Love?

Source Link: The Human Nose Might Be Home To The Next New Antibiotic

Filed Under: News

Primary Sidebar

  • JWST Confirms Day-Long Gamma-Ray Burst Was The Most Energetic Event Humanity Has Witnessed
  • These Birds Self-Cannibalize Their Own Organs To Complete Their Non-Stop 11,000-Kilometer Migration
  • “I’ve Never Seen This Happen Before”: Space Junk Found In Western Australian Desert Reported To Have Landed On Fire
  • Armadillo Girdled Lizards Turn Themselves Into An Ouroboros To Protect Their Underbelly
  • Opium Found In Rare Ancient Egyptian Vase Dedicated To “Great King” Xerxes
  • COVID-19 mRNA Vaccines Boosted Survival Almost 5-Fold In Some Cancer Patients
  • Sleuths Uncover Hidden Message In CIA’s Mysterious Kryptos Sculpture After 35 Years
  • Meat-Eating In US Cities Emits 329 Million Tons Of Carbon – But This Could Be Cut In Half
  • The World’s Oldest Known Chimpanzee Is Over 80 Years Old, And He’s Our Favorite Chill Childminder
  • Mysterious JWST Object “Capotauro” Might Be The First Galaxy In The Universe
  • 4.4-Million-Year-Old Ankle Bone Suggests Humans Evolved From African Ape-Like Ancestor
  • Hib: The Deadliest Disease You Might Never Have Heard Of (Because Vaccines Are Awesome)
  • The Legend Of Ol’ Rip The Horned Toad Who Reportedly Survived 31 Years Of Hibernation And Met President Coolidge
  • Newly Discovered “Reset Button” Lets Mathematicians Undo Any Rotation
  • Bear-Sized Snow Sloths? Meet Megalonyx, The Ice Age Giants That Lived Until 13,000 Years Ago
  • Why Can’t Mormons Drink Coffee?
  • In 1997, A Zoo Chimp Amazed Scientists By Gathering Rocks To Throw At Visitors
  • YouTuber Films Laser Light At 2 Billion Frames Per Second In His Garage
  • The Time To Watch Comet Lemmon Is Now
  • Ig Nobel-Winning “Butt-Breathing” Technique Moves One Step Closer To Saving Lives
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version